Evotec, Halozyme

Evotec jumps on report Halozyme expressed takeover interest
ADRs quickly rose 14% on a report that Halozyme Therapeutics (HALO) has expressed takeover interest. Halozyme has recently expressed interest in purchasing Evotec for ~€11 per share, according to a Bloomberg report on Thursday,
Halozyme weighing buyout of drugmaker Evotec, Bloomberg News reports
German drugmaker Evotec is attracting takeover interest from U.S.-based Halozyme Therapeutics, Bloomberg News reported on Thursday. Halozyme has recently expressed interest in acquiring Evotec at about 11 euros per share,
Evotec Shares Jump After Triton Acquires Stake
Evotec shares soared after the company said private equity group Triton had acquired about 10% of its stock. Luxembourg-based private equity firm Triton acquired a total of 17,730,913 ordinary shares in a series of transactions totaling 131 million euros ($140.4 million), the German biotechnology company said.
Evotec shares jump as Triton becomes biggest shareholder with near 10% stake
(Reuters) - Shares in Evotec jumped as much as 13.3% on Monday after regulatory filings showed private equity firm Triton had built an over 9% stake in the German drug development company. Evotec confirmed to Reuters that Triton now holds a 9.99% stake in ...
Evotec rallies after Bloomberg says Triton weighing takeover bid
Triton Partners, is considering a takeover bid Evotec , Eyk Henning of Bloomberg reported earlier, citing people familiar with the matter. Triton is among several investment firms
Evotec soars on Triton's near 10% stake, report it weighs buyout bid
(Reuters) -Shares in Evotec soared 22% on Monday after private equity firm Triton confirmed a close to 10% stake in the German drug development company, and a media report said it was weighing a takeover bid.
Evotec surges on report Triton Partners evaluating takeover (Update)
Updates shares, adds further details. Evotec SE (NASDAQ:EVO) ADRs surged 18% after a report that Triton Partners is considering a takeover offer for the German drug developer. Triton is among one of several investment companies that have been looking at a potential deal for Evotec (EVO) in recent months,
Private Equity Triton Partners Takes Around 10% Stake In Evotec, Reportedly Mulls Potential Takeover Deal
Germany-based Evotec SE (NASDAQ:EVO) is trading on Monday after a report that suggests the company is a takeover target. The ...
FierceBiotech3d
Evotec, after stock-tanking blows, attracts private equity buyout interest: report
Evotec’s struggles have put it in the crosshairs of private equity groups. After seeing the company’s share price fall ...
Halozyme Therapeutics Proposes To Acquire Evotec For EUR 11.00/shr In Cash
Halozyme Therapeutics Inc. (HALO) confirmed it has submitted a non-binding proposal to the Management Board and Supervisory Board of ...
Halozyme Therapeutics Bids to Acquire German Competitor Evotec
Halozyme Therapeutics submitted a bid to acquire German drug developer Evotec in a deal with an equity value of 2 billion euros ($2.11 billion.) ...
Halozyme Confirms Proposal to Combine with Evotec for €11.00 Per Share in an All-Cash Transaction
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme" or the "Company") confirmed it has submitted a non-binding proposal to ...
SDxCentral9h
Halozyme Proposes €2 Billion Acquisition of Evotec at €11 Per Share
Combination Would Create a Global Innovative Services Company with a Unique Set of Differentiated Technologies, a Deep Pipeline, and Best-in-class Industry Team Storage-Area Networking (SAN) DIEGO, ...
Business Insider17h
Evotec attracts takeover interest from Halozyme, Bloomberg says
Evotec price target lowered to EUR 11.60 from EUR 12 at RBC Capital Evotec rallies after Bloomberg says Triton weighing takeover bid Evotec Reports Strategic Growth Amidst Revenue Challenges ...